Skip to main content
Erschienen in: Supportive Care in Cancer 1/2023

01.01.2023 | Review Article

What are the outcomes of hospice care for cancer patients? A systematic review

verfasst von: Simin Sharafi, Atefeh Ziaee, Hanie Dahmardeh

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Over the past 2 decades, cancer has been the leading cause of death worldwide. Accordingly, cancer patients are the largest group of patients admitted to a hospice, accounting for 40% of overall hospice admissions every year. Therefore, the purpose of this systematic review is to investigate the outcomes of caring for cancer patients at hospices.

Methods

PubMed, Scopus, and Web of Science databases were searched for English language articles published during the period from January 2008 to January 2022. The keywords used to search in this systematic review were included hospice, cancer, and neoplasm (for PubMed search only), which were searched in the titles and abstracts of the articles.

Results

Out of 803 articles found in the initial search, 38 were selected based on inclusion criteria. The studies indicated that hospice care resulted in outcomes such as reduced referral and admission to the emergency department (only one study reporting opposite results), reduced length and number of hospital admissions, reduced use of chemotherapy and radiotherapy, increased pain reports, improved pain management, enhanced end-of-life quality, significantly reduced cost of treatment, reduced number of invasive interventions, death at home, increased survival and satisfaction of patients, and poor nutritional support.

Conclusion

Given the numerous and significant benefits of care in a hospice for cancer patients, health managers are recommended to consider developing hospices and introducing patients to these centers. Besides, they need to compensate for some shortcomings by, for example, providing better nutritional support and developing a care plan based on the type of cancers that the patients are suffering in hospices so that more specialized services can be delivered.
Literatur
19.
Zurück zum Zitat Karikari-Martin P, McCann JJ, Farran CJ, Hebert LE, Haffer SC, Phillips M (2016) Race, Any cancer, income, or cognitive function: what inf luences hospice or aggressive services use at the end of life among community-dwelling medicare beneficiaries? Am J Hosp Palliat Care 33(6):537–545. https://doi.org/10.1177/1049909115574263CrossRef Karikari-Martin P, McCann JJ, Farran CJ, Hebert LE, Haffer SC, Phillips M (2016) Race, Any cancer, income, or cognitive function: what inf luences hospice or aggressive services use at the end of life among community-dwelling medicare beneficiaries? Am J Hosp Palliat Care 33(6):537–545. https://​doi.​org/​10.​1177/​1049909115574263​CrossRef
37.
Zurück zum Zitat Lin WY, Chiu TY, Ho CT, Davidson LE, Hsu HS, Liu CS et al (2014) Hospice shared-care saved medical expenditure and reduced the likelihood of intensive medical utilization among advanced cancer patients in Taiwan–a nationwide survey. Support Care Cancer 22(7):1907–1914. https://doi.org/10.1007/s00520-014-2168-5CrossRef Lin WY, Chiu TY, Ho CT, Davidson LE, Hsu HS, Liu CS et al (2014) Hospice shared-care saved medical expenditure and reduced the likelihood of intensive medical utilization among advanced cancer patients in Taiwan–a nationwide survey. Support Care Cancer 22(7):1907–1914. https://​doi.​org/​10.​1007/​s00520-014-2168-5CrossRef
47.
48.
Zurück zum Zitat LeBlanc TW, Abernethy AP, Casarett DJ (2015) What is different about patients with hematologic malignancies? A retrospective cohort study of cancer patients referred to a hospice research network. J Pain Symptom Manage 49(3):505–512CrossRef LeBlanc TW, Abernethy AP, Casarett DJ (2015) What is different about patients with hematologic malignancies? A retrospective cohort study of cancer patients referred to a hospice research network. J Pain Symptom Manage 49(3):505–512CrossRef
Metadaten
Titel
What are the outcomes of hospice care for cancer patients? A systematic review
verfasst von
Simin Sharafi
Atefeh Ziaee
Hanie Dahmardeh
Publikationsdatum
01.01.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2023
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-022-07524-2

Weitere Artikel der Ausgabe 1/2023

Supportive Care in Cancer 1/2023 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.